Browsing Bergen Open Research Archive by Author "Forster, Rachel Bedenis"
Now showing items 1-7 of 7
-
Association between medical androgen deprivation therapy and long-term cardiovascular disease and all-cause mortality in nonmetastatic prostate cancer
Forster, Rachel Bedenis; Engeland, Anders; Kvåle, Rune; Hjellvik, Vidar; Bjørge, Tone (Journal article; Peer reviewed, 2022)Studies have suggested that prostate cancer (PCa) patients receiving androgen deprivation therapy (ADT) are at increased risk of developing or exacerbating cardiovascular disease (CVD). We aimed to explore the association ... -
Cardiovascular outcomes after curative prostate cancer treatment: A population-based cohort study
Kjellstadli, Camilla; Forster, Rachel Bedenis; Myklebust, Tor Åge; Bjørge, Tone; Bønaa, Kaare Harald; Helle, Svein Inge; Kvåle, Rune (Journal article; Peer reviewed, 2023-03-31)Objective: To investigate differences in cardiovascular disease (CVD) morbidity and mortality after radical prostatectomy or definitive radiotherapy with or without androgen deprivation therapy (ADT). Materials and ... -
Cohort profile: Outcomes & Multi-morbidity In Type 2 diabetes (OMIT) – a national registry-based observational cohort with focus on care and treatment of key high-risk groups in Norway
Forster, Rachel Bedenis; Strandberg, Ragnhild Bjarkøy; Tibballs, Katrina Louise Bø; Nøkleby, Kjersti; Berg, Tore Julsrud; Iversen, Tor; Hagen, Terje P.; Richardsen, Kåre Rønn; Cooper, John; Sandberg, Sverre; Løvaas, Karianne Fjeld; Nilsen, Roy Miodini; Iversen, Marjolein M.; Jenum, Anne Karen; Buhl, Esben Selmer (Journal article; Peer reviewed, 2022)Purpose The ‘Outcomes & Multi-morbidity in Type 2 Diabetes’ (OMIT) is an observational registry-based cohort of Norwegian patients with type 2 diabetes (T2D) established to study high-risk groups often omitted from randomised ... -
How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registry-based cohort study from Norway
Igland, Jannicke; Forster, Rachel Bedenis; Jenum, Anne Karen; Strandberg, Ragnhild Bjarkøy; Berg, Tore Julsrud; Røssberg, Jan Ivar; Iversen, Marjolein M.; Buhl, Esben Selmer (Journal article; Peer reviewed, 2024)Objective: The prescription-based Rx-risk index has previously been developed to measure multimorbidity. We aimed to adapt and evaluate the validity of the Rx-risk index in prediction of mortality among persons with type ... -
Hva betyr tidligere hjerte- og karsykdom eller kreft for risiko for død etter påvist SARS-CoV-2?
Kvåle, Rune; Bønaa, Kaare Harald; Forster, Rachel Bedenis; Gravningen, Kirsten Midttun; Juliusson, Pétur Benedikt; Myklebust, Tor Åge (Journal article; Peer reviewed, 2020)BAKGRUNN Hjerte- og karsykdommer og kreft har vært beskrevet som mulige risikofaktorer for død av covid-19. Hensikten med studien er å undersøke om tidligere påvist hjerte- og karsykdom eller kreft har påvirket risiko for ... -
Lower education and immigrant background are associated with lower participation in a diabetes education program - Insights from adult patients in the Outcomes & Multi-morbidity In Type 2 diabetes cohort (OMIT)
Strandberg, Ragnhild Bjarkøy; Nilsen, Roy Miodini; Pouwer, Frans; Igland, Jannicke; Forster, Rachel Bedenis; Jenum, Anne Karen; Buhl, Esben Selmer; Iversen, Marjolein Memelink (Journal article; Peer reviewed, 2023)Objectives Diabetes educational programmes should be offered to patients with type 2 diabetes mellitus (T2DM). We assessed the proportion of diabetes educational program participation among adults with T2DM, and its ... -
Treatment and 30-day mortality after myocardial infarction in prostate cancer patients: A population-based study from Norway
Forster, Rachel Bedenis; Kjellstadli, Camilla; Myklebust, Tor Åge; Egeland, Grace M.; Sulo, Gerhard; Bjørge, Tone; Bønaa, Kaare Harald; Juliusson, Pétur Benedikt; Kvåle, Rune (Journal article; Peer reviewed, 2023)Introduction: There is limited knowledge about the use of invasive treatment and mortality after acute myocardial infarction (AMI) in prostate cancer (PCa) patients. We therefore wanted to compare rates of invasive treatment ...